What are analysts'target prices for Interpace Biosciences'stock?
1 brokerages have issued twelve-month target prices for Interpace Biosciences' stock. Their forecasts range from $11.00 to $11.00. On average, they expect Interpace Biosciences' stock price to reach $11.00 in the next twelve months.
Does Interpace Biosciences stock pay a dividend?
Interpace Biosciences does not currently pay a dividend. Interpace Biosciences does not have a long track record of dividend growth. In the past three months, Interpace Biosciences insiders have not sold or bought any company stock. 54.40% of the stock of Interpace Biosciences is held by insiders.
What is the price of idxg stock?
One share of IDXG stock can currently be purchased for approximately $6.75. How much money does Interpace Biosciences make? Interpace Biosciences has a market capitalization of $28.15 million and generates $32.40 million in revenue each year.
Why choose Interpace diagnostics?
Interpace Diagnostics provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services, including such widely respected tests as PancraGEN ®, ThyGeNEXT ®, ThyraMIR ®, RespriDX ® and BarreGEN ®.
Should I buy or sell Interpace Biosciences stock right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Interpace Biosciences in the last twelve months. There are curren...
When is Interpace Biosciences' next earnings date?
Interpace Biosciences is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for...
How were Interpace Biosciences' earnings last quarter?
Interpace Biosciences, Inc. (NASDAQ:IDXG) issued its quarterly earnings data on Monday, May, 16th. The business services provider reported ($0.52)...
Who are Interpace Biosciences' key executives?
Interpace Biosciences' management team includes the following people: Dr. Thomas W. Burnell Ph.D. , Pres, CEO & Director (Age 58, Pay $425k) Mr....
Who are some of Interpace Biosciences' key competitors?
Some companies that are related to Interpace Biosciences include Laboratory Co. of America (LH) , Quest Diagnostics (DGX) , DaVita (DVA) , Chem...
What other stocks do shareholders of Interpace Biosciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Interpace Biosciences investors own include Inovio Pharmac...
What is Interpace Biosciences' stock symbol?
Interpace Biosciences trades on the NASDAQ under the ticker symbol "IDXG."
What is Interpace Biosciences' stock price today?
One share of IDXG stock can currently be purchased for approximately $3.22.
How much money does Interpace Biosciences make?
Interpace Biosciences (NASDAQ:IDXG) has a market capitalization of $13.62 million and generates $41.31 million in revenue each year.
What is the consensus rating of Interpace Biosciences?
What is the official website of Interpace Biosciences?
Interpace Biosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
What is Interpace Biosciences?
The official website for Interpace Biosciences is www.interpace.com.
What is the IDXG symbol?
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Does Interpace Biosciences pay dividends?
Interpace Biosciences trades on the NASDAQ under the ticker symbol "IDXG."
What is Interpace Biosciences?
Interpace Biosciences does not currently pay a dividend.
Where is Interpace Biosciences located?
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
How much is Interpace Diagnostics stock worth in 2021?
in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Is Interpace Diagnostics Group stock A Buy?
The Interpace Diagnostics Group stock price gained 0.48% on the last trading day (Friday, 2nd Jul 2021), rising from $10.40 to $10.45. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.04% from a day low at $10.20 to a day high of $10.51. The price has fallen in 5 of the last 10 days, but is still up by 0.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 thousand more shares were traded than the day before. In total, 10 thousand shares were bought and sold for approximately $105.24 thousand.